Correction: Influence of CYP3A polymorphisms on tacrolimus pharmacokinetics in kidney transplant recipients.
2021
Ibtissem Hannachi, and
Zohra Chadli, and
Emna Kerkeni, and
Abdessalem Kolsi, and
Mouna Hammouda, and
Amel Chaabane, and
Nadia Ben Fredj, and
Yvan Touitou, and
Naceur A Boughattas, and
Karim Aouam
Faculty of Sciences of Bizerte, Carthage University, Tunis, Tunisia. hannachi_ibtissem@yahoo.fr.
UI
MeSH Term
Description
Entries
Related Publications
Ibtissem Hannachi, and
Zohra Chadli, and
Emna Kerkeni, and
Abdessalem Kolsi, and
Mouna Hammouda, and
Amel Chaabane, and
Nadia Ben Fredj, and
Yvan Touitou, and
Naceur A Boughattas, and
Karim Aouam
May 2008,
Medical science monitor : international medical journal of experimental and clinical research,
Ibtissem Hannachi, and
Zohra Chadli, and
Emna Kerkeni, and
Abdessalem Kolsi, and
Mouna Hammouda, and
Amel Chaabane, and
Nadia Ben Fredj, and
Yvan Touitou, and
Naceur A Boughattas, and
Karim Aouam
Ibtissem Hannachi, and
Zohra Chadli, and
Emna Kerkeni, and
Abdessalem Kolsi, and
Mouna Hammouda, and
Amel Chaabane, and
Nadia Ben Fredj, and
Yvan Touitou, and
Naceur A Boughattas, and
Karim Aouam
January 2018,
Pharmacogenomics and personalized medicine,
Ibtissem Hannachi, and
Zohra Chadli, and
Emna Kerkeni, and
Abdessalem Kolsi, and
Mouna Hammouda, and
Amel Chaabane, and
Nadia Ben Fredj, and
Yvan Touitou, and
Naceur A Boughattas, and
Karim Aouam
December 2002,
Clinical pharmacology and therapeutics,
Ibtissem Hannachi, and
Zohra Chadli, and
Emna Kerkeni, and
Abdessalem Kolsi, and
Mouna Hammouda, and
Amel Chaabane, and
Nadia Ben Fredj, and
Yvan Touitou, and
Naceur A Boughattas, and
Karim Aouam
Ibtissem Hannachi, and
Zohra Chadli, and
Emna Kerkeni, and
Abdessalem Kolsi, and
Mouna Hammouda, and
Amel Chaabane, and
Nadia Ben Fredj, and
Yvan Touitou, and
Naceur A Boughattas, and
Karim Aouam
Ibtissem Hannachi, and
Zohra Chadli, and
Emna Kerkeni, and
Abdessalem Kolsi, and
Mouna Hammouda, and
Amel Chaabane, and
Nadia Ben Fredj, and
Yvan Touitou, and
Naceur A Boughattas, and
Karim Aouam
Ibtissem Hannachi, and
Zohra Chadli, and
Emna Kerkeni, and
Abdessalem Kolsi, and
Mouna Hammouda, and
Amel Chaabane, and
Nadia Ben Fredj, and
Yvan Touitou, and
Naceur A Boughattas, and
Karim Aouam
Ibtissem Hannachi, and
Zohra Chadli, and
Emna Kerkeni, and
Abdessalem Kolsi, and
Mouna Hammouda, and
Amel Chaabane, and
Nadia Ben Fredj, and
Yvan Touitou, and
Naceur A Boughattas, and
Karim Aouam
June 2014,
European journal of clinical pharmacology,
Ibtissem Hannachi, and
Zohra Chadli, and
Emna Kerkeni, and
Abdessalem Kolsi, and
Mouna Hammouda, and
Amel Chaabane, and
Nadia Ben Fredj, and
Yvan Touitou, and
Naceur A Boughattas, and
Karim Aouam